Dasatinib Targets B-Lineage Cells but Does Not Provide an Effective Therapy for Myeloproliferative Disease in c-Cbl RING Finger Mutant Mice

• Johanna M. Duyvestyn,

  Affiliation School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia

  ⨯
• Samuel J. Taylor,

  Affiliation School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia

  ⨯
• Samantha A. Dagger,

  Affiliation School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia

  ⨯
• Marlene Orandle,

  Affiliation Infectious Disease Pathogenesis Section, Comparative Medicine Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America

  ⨯
• Herbert C. Morse III,

  Affiliation Virology and Cellular Immunology Section, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America

  ⨯
• Christine B. F. Thien,

  Affiliation School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia

  ⨯
• Wallace Y. Langdon

  * E-mail: wally.langdon@uwa.edu.au

  Affiliation School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, Australia

  ⨯